Research center

The Institute of Molecular and Cellular Biology of Rosario, IBR, is a research institute affiliated with CONICET (National Scientific and Technical Research Council) and the National University of Rosario.

Its mission is the generation, dissemination, and application of scientific knowledge in biological sciences through excellence in research, education, and the transfer of this knowledge to the productive sector, healthcare, decision-makers, and the community. It is one of the leading institutes in biological sciences in Argentina and was a pioneer in the development of structural biology in the region, installing the country's first high-field NMR spectrometer.

The Institute is composed of approximately 60 researchers, 100 doctoral and postdoctoral fellows, and support staff consisting of around 30 professionals, technicians, administrators, and interns, totaling around 200 individuals. Including roughly 60 undergraduate students working on their bachelor's theses, there are currently approximately 260 people engaged in scientific activities at IBR.

Over the past few years, both the quantity and the quality of the institute's scientific publications have increased significantly. Its mission is driven by excellence in the pursuit of knowledge, with a focus on societal needs. In this paradigm, the knowledge generated at IBR has led to the creation of companies, patents, and products in the biotechnology and healthcare market.

Research lines

Since its creation as a multidisciplinary Institute in biological sciences, the IBR has carried out various lines of research in biology and biotechnology of development in vertebrates and plants; molecular, cellular and structural biology of infectious and neurodegenerative diseases; plant cell and molecular biology; and microbial physiology and genetics.

Instrumentation​

Thank you @cziscience for the amazing event 🙌 We're grateful for the opportunity to participate and collaborate. Looking forward to what’s next!

#ImagingTheFuture

This project has been made possible in part by a grant from the Chang Zuckerberg Initiative DAF, an advised fund of Silicon Valley.